Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced preparation method for HER2 inhibitor Tucatinib using Pd(acac)2 catalysis. Offers high purity, simplified purification, and cost-effective manufacturing for pharma supply chains.
Patent CN110590569B reveals a novel one-pot synthesis for tulobuterol, utilizing bromination byproducts to enhance yield and reduce costs in pharmaceutical intermediates manufacturing.
Novel patent CN119306612A enables high trans-selectivity. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Patent CN120136859A reveals a novel binaphthyl ligand for synthesizing high-purity seven-membered nitrogen heterocycles, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed route for alpha-amino acid esters using alkenyl ethers. Offers mild conditions and high atom economy for pharmaceutical intermediate manufacturing.
Patent CN102295638A details a novel one-pot method for Lapatinib synthesis, eliminating toxic tin reagents and improving purity for reliable API intermediate supply chains.
Patent CN117865874A details Pd-catalyzed olefin C-H amination for high-purity tetrahydroindole derivatives, offering scalable solutions for pharmaceutical intermediates manufacturing.
Patent CN112441978B reveals a novel route for MHPE production using DEMME, offering significant cost reduction and high purity for Topramezone manufacturing.
Novel 5-step synthesis of Trilaciclib via CN114014864A. Offers high purity, mild conditions, and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN112441934B discloses a mild copper-catalyzed method for halogenated oxaallylamine synthesis, offering reliable supply and cost reduction in API manufacturing.
Novel copper-catalyzed method for halogenated oxaallylamines. Reduces steps, improves yield for beta-blocker intermediates. Ideal for API manufacturing cost reduction.
Patent CN116023359B reveals mild catalytic route for aminothiophene intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturing.
Patent CN116023359A reveals a breakthrough copper-catalyzed amination route for aminothiophenes, offering superior yields and safety over traditional nitration for pharmaceutical supply chains.
Novel patent CN107011218A enables high ee value synthesis of chiral amines reducing steps and improving supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN107501267B reveals Pd-catalyzed asymmetric allylic amination for high-purity nucleoside intermediates. Enables cost reduction and supply chain reliability.
Novel cyclization route for spiro-piperidine intermediates offering high yield and scalability for pharmaceutical manufacturing.
Patent CN112920066A reveals a novel palladium-catalyzed route for alpha-amino acid esters, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN116924925B details catalyst-free tetracaine synthesis. Offers high yield and mild conditions for reliable pharmaceutical intermediate supply chains.
Novel route avoids toxic reagents like selenium dioxide, offering safer manufacturing and cost reduction for pharmaceutical intermediates supply chains.
Novel reductive amination route for bromhexine hydrochloride offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing partners.